<DOC>
	<DOCNO>NCT01955707</DOCNO>
	<brief_summary>The primary objective study determine whether one 300 mg dose intravenous ( IV ) natalizumab reduces change infarct volume Baseline Day 5 magnetic resonance imaging ( MRI ) participant acute ischemic stroke give ≤6 hour &gt; 6 ≤9 hour last known normal ( LKN ) . The secondary objective study study population follow : ass efficacy natalizumab change infarct volume Baseline Day 30 ; assess efficacy natalizumab change infarct volume 24 hour Day 5 Day 30 ; assess efficacy natalizumab clinical measure stroke outcome ; ass safety natalizumab participant acute ischemic stroke .</brief_summary>
	<brief_title>Effect Natalizumab Infarct Volume Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Natalizumab</mesh_term>
	<criteria>Key Diagnosis acute ischemic stroke . Score ≥6 point National Institute Health Stroke Scale ( NIHSS ) Screening . At least 1 acute infarct large diameter 2 cm Baseline brain diffusionweighted imaging ( DWI ) . Participants receive reperfusion therapy may eligible participate must meet eligibility criterion perform Baseline study magnetic resonance imaging ( MRI ) reperfusion therapy complete . Subjects childbearing potential must practice effective contraception study willing able continue contraception least 3 month dose study treatment . Key Presence intracranial hemorrhage ( ICH ) head compute tomography ( CT ) nonpetechial ICH screening MRI . Stroke isolate brainstem . Presence coma Expected die OR unable evaluate within 5 day . Hypotension require use intravenous ( IV ) vasopressor support systolic blood pressure &lt; 90 mmHg time randomization . Known prior treatment natalizumab . Immunocompromised subject , determine Investigator . History progressive multifocal leukoencephalopathy ( PML ) . Contraindications MRI , e.g. , implant pacemaker contraindicate implanted metal device , history risk side effect gadolinium , claustrophobia medically manage . NOTE : Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>